Pier 88 Investment Partners LLC Dexcom Inc Transaction History

Pier 88 Investment Partners LLC

$76.1 Million
Q3 2024

A detailed history of Pier 88 Investment Partners LLC transactions in Dexcom Inc stock. As of the latest transaction made, Pier 88 Investment Partners LLC holds 6,400 shares of DXCM stock, worth $481,535. This represents 0.56% of its overall portfolio holdings.

Number of Shares

6,400

Previous 13,630 53.04%

Holding current value

$481,535

Previous $1.55 Million 72.3%

% of portfolio

0.56%

Previous 1.78%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$64.0 - $116.06 $462,720 - $839,113	-7,230 Reduced 53.04%	6,400 $428,000
Q2 2024 Aug 06, 2024	BUY	$110.31 - $140.45 $432,415 - $550,564	3,920 Added 40.37%	13,630 $1.55 Million
Q1 2024 May 10, 2024	BUY	$114.22 - $140.1 $214,733 - $263,388	1,880 Added 24.01%	9,710 $1.35 Million
Q4 2023 Feb 09, 2024	SELL	$75.49 - $124.16 $372,920 - $613,350	-4,940 Reduced 38.68%	7,830 $971,000
Q3 2023 Nov 09, 2023	SELL	$86.06 - $137.93 $508,614 - $815,166	-5,910 Reduced 31.64%	12,770 $1.19 Million
Q2 2023 Aug 07, 2023	SELL	$112.47 - $130.98 $280,050 - $326,140	-2,490 Reduced 11.76%	18,680 $2.4 Million
Q1 2023 May 09, 2023	BUY	$104.0 - $122.92 $499,200 - $590,016	4,800 Added 29.32%	21,170 $2.46 Million
Q4 2022 Feb 08, 2023	SELL	$84.98 - $122.67 $408,753 - $590,042	-4,810 Reduced 22.71%	16,370 $1.85 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $995,603 - $1.23 Million	13,040 Added 160.2%	21,180 $1.71 Million
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $94,098 - $183,919	1,384 Added 20.49%	8,140 $607,000
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $169,344 - $234,359	1,800 Added 36.32%	6,756 $3.46 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $77,922 - $97,692	-600 Reduced 10.8%	4,956 $2.66 Million
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $183,541 - $246,269	1,720 Added 44.84%	5,556 $3.04 Million
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $77,750 - $103,612	960 Added 33.38%	3,836 $1.64 Million
Q4 2020 Feb 12, 2021	SELL	$78.0 - $104.5 $96,330 - $129,057	-1,235 Reduced 30.04%	2,876 $4.25 Million
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $859 - $1,016	9 Added 0.22%	4,111 $1.69 Million
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $18,302 - $30,759	292 Added 7.66%	4,102 $1.66 Million
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $71,685 - $113,445	1,500 Added 64.94%	3,810 $1.03 Million
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $84,592 - $132,339	2,310 New	2,310 $505,000
Q1 2019 May 15, 2019	SELL	$28.07 - $38.18 $35,929 - $48,870	-1,280 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$26.99 - $37.37 $34,547 - $47,833	1,280 New	1,280 $153,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier 88 Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier 88 Investment Partners LLC with notifications on news.

Account

Pier 88 Investment Partners LLC Dexcom Inc Transaction History